Paper39512331
Nanotechnology in retinal diseases: From disease diagnosis to therapeutic applications.
Kaur G and 2 others. Biophys Rev (Melville), 2024. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Nanotechnology in retinal diseases: From disease diagnosis to therapeutic applications. Papers, record 39512331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39512331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 EY004068 | NEI NIH HHS | United States | P30EY004068 | PubMed | NIH RePORTER |
| R01 EY029709 | NEI NIH HHS | United States | R01EY029709 | PubMed | NIH RePORTER |
References143
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29459654 | Photoelectrochemical modulation of neuronal activity with free-standing coaxial silicon nanowires. | Nat Nanotechnol | 2018 | https://conductscience.org/library/papers/29459654 | PubMed |
| 2 | 37887287 | Assessment of Inner Blood-Retinal Barrier: Animal Models and Methods. | Cells | 2023 | https://conductscience.org/library/papers/37887287 | PubMed |
| 3 | 37814270 | Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation. | Mol Cancer | 2023 | https://conductscience.org/library/papers/37814270 | PubMed |
| 4 | 37514191 | Next-Generation Nanomedicine Approaches for the Management of Retinal Diseases. | Pharmaceutics | 2023 | https://conductscience.org/library/papers/37514191 | PubMed |
| 5 | 18686775 | Drug delivery and nanoparticles:applications and hazards. | Int J Nanomedicine | 2008 | https://conductscience.org/library/papers/18686775 | PubMed |
| 6 | 26606532 | Ultrathin Polyimide Membrane as Cell Carrier for Subretinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigment Epithelium. | PLoS One | 2015 | https://conductscience.org/library/papers/26606532 | PubMed |
| 7 | 31581687 | Single-Crystalline Metal Oxide Nanostructures Synthesized by Plasma-Enhanced Thermal Oxidation. | Nanomaterials (Basel) | 2019 | https://conductscience.org/library/papers/31581687 | PubMed |
| 8 | 33277608 | Engineering precision nanoparticles for drug delivery. | Nat Rev Drug Discov | 2021 | https://conductscience.org/library/papers/33277608 | PubMed |
| 9 | 29379334 | Applications of nanoparticle systems in drug delivery technology. | Saudi Pharm J | 2018 | https://conductscience.org/library/papers/29379334 | PubMed |
| 10 | 25066531 | Yttrium oxide nanoparticles prevent photoreceptor death in a light-damage model of retinal degeneration. | Free Radic Biol Med | 2014 | https://conductscience.org/library/papers/25066531 | PubMed |
| 11 | 24451140 | Magnetic nanoparticles as intraocular drug delivery system to target retinal pigmented epithelium (RPE). | Int J Mol Sci | 2014 | https://conductscience.org/library/papers/24451140 | PubMed |
| 12 | 23826539 | Nanoparticles in the ocular drug delivery. | Int J Ophthalmol | 2013 | https://conductscience.org/library/papers/23826539 | PubMed |
| 13 | 30797953 | Nanoparticle technology and stem cell therapy team up against neurodegenerative disorders. | Adv Drug Deliv Rev | 2019 | https://conductscience.org/library/papers/30797953 | PubMed |
| 14 | 25695336 | Ocular tissue engineering: current and future directions. | J Funct Biomater | 2015 | https://conductscience.org/library/papers/25695336 | PubMed |
| 15 | 29986546 | Human 3D Cultures as Models for Evaluating Magnetic Nanoparticle CNS Cytotoxicity after Short- and Repeated Long-Term Exposure. | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/29986546 | PubMed |
| 16 | 35494641 | Recent Developments of Nanostructures for the Ocular Delivery of Natural Compounds. | Front Chem | 2022 | https://conductscience.org/library/papers/35494641 | PubMed |
| 17 | 27233037 | Survival and Functionality of hESC-Derived Retinal Pigment Epithelium Cells Cultured as a Monolayer on Polymer Substrates Transplanted in RCS Rats. | Invest Ophthalmol Vis Sci | 2016 | https://conductscience.org/library/papers/27233037 | PubMed |
| 18 | 34641139 | Hyaluronic Acid-Based Gold Nanoparticles for the Topical Delivery of Therapeutics to the Retina and the Retinal Pigment Epithelium. | Polymers (Basel) | 2021 | https://conductscience.org/library/papers/34641139 | PubMed |
| 19 | 30827682 | Mammalian Near-Infrared Image Vision through Injectable and Self-Powered Retinal Nanoantennae. | Cell | 2019 | https://conductscience.org/library/papers/30827682 | PubMed |
| 20 | 20877651 | Structure-function correlation of the human central retina. | PLoS One | 2010 | https://conductscience.org/library/papers/20877651 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42005706 | Innovative Applications of Nanomaterials in the Diagnosis and Treatment of Ocular Diseases: Targeted Delivery, Intelligent Therapy, Diagnostic Breakthroughs, and Synergistic Strategies with Stem Cells and Biomaterials. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42005706 | PubMed |
| 41331389 | Multifunctional nanoplatforms for optic nerve regeneration integrating anti-inflammatory, epigenetic, and ionic mechanisms with emerging artificial intelligence technologies. | Cell Biol Toxicol | 2025 | https://conductscience.org/library/papers/41331389 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39512331
GET https://conductscience.org/api/papers/v1/39512331/references?page=2